Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
about
Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML PatientsSecondary treatment of acute graft-versus-host disease: a critical reviewLong-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumabPrognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.Recent advances in the management of graft-versus-host disease.Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD.Management of acute graft-versus-host disease in children.Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patientsEfficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.Infectious complications associated with monoclonal antibodies and related small moleculesImmune recovery after allogeneic hematopoietic stem cell transplantation: is it time to revisit how patients are monitored?Treatment of graft-versus-host disease with monoclonal antibodies and related fusion proteins.Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease.Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies.Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study.Unintended Immunological Consequences of Biologic Therapy.Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.Long-term follow-up of corticosteroid refractory acute GVHD treated with an Inolimomab-based algorithm: a single center experience.Long-term follow-up of children treated with daclizumab for steroid-refractory gastrointestinal GvHD in a prospective study.Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.α1-Antitrypsin Infusion for treatment of Steroid Resistant Acute Graft-versus-Host Disease.Regional intra-arterial steroid treatment in 120 patients with steroid-resistant or -dependent GvHD.Non-Coding RNA Mediated Regulation of Allogeneic T Cell Responses After Hematopoietic Transplantation.
P2860
Q26799602-16D5F02D-0DB9-4463-9772-96BFEF03EDB3Q26823275-00FF1607-D5A7-4670-B3F0-FA3EA62016ECQ33707389-D9041C52-510A-4D57-8B92-8D2AF34CE50DQ33838584-1D6AF391-53F8-4062-873B-B5541B10224FQ34138063-398ADC57-34AB-43E3-916F-36755F927502Q34428890-D7996B78-FAA1-40AD-B3FA-BA2C76C84720Q34441886-9A65F5B1-7A68-4A33-B7EC-04D2F46EA835Q35583009-23D5CA79-791A-478B-AC21-02C520461B7FQ35669073-C81558D8-4CF3-4EBE-96F3-82CA32616A51Q35760517-992CA27E-C811-4988-8840-432D82D3174DQ36113205-7AC64227-8454-457D-9A96-0B10BB3B4C6FQ37156636-47E155B9-E779-42C9-949E-320689B2A597Q37211141-A56DCD99-6F9B-469B-93F2-280DC331839EQ37810286-635DFD52-F00C-4345-9E7F-780EF22CBAB1Q38064454-15248233-30CD-4258-B34D-E7810EE68FC2Q38226527-E265E76E-073D-4393-B18F-1C0CA8FBC7CCQ38839140-B4B4B39A-EC57-463D-8E85-6E55DF55C9D3Q38871098-1F0BE4AD-16E5-4BCB-B98D-CCDFC9139217Q39264020-502D34A1-9172-40D6-B603-7B93C32CA59DQ42270601-49BA0906-CCB8-403A-BE1A-E607B529C7F1Q45722998-AA90C21B-DCD3-45DA-962F-DC7F3DF5C3F4Q48362201-A2D53D91-0EC1-4F97-8DC0-CB4BDED9E744Q50044411-04BD0B6D-9DF8-486C-818D-4F290EA544B9Q50561008-F967709B-3D83-4342-8C9F-F748CDFAE686Q55396614-B2017C86-C5BD-4DCD-AAC9-3FF548F3E13A
P2860
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Long-term follow-up of patient ...... y acute graft-vs-host disease.
@en
type
label
Long-term follow-up of patient ...... y acute graft-vs-host disease.
@en
prefLabel
Long-term follow-up of patient ...... y acute graft-vs-host disease.
@en
P2093
P356
P1476
Long-term follow-up of patient ...... y acute graft-vs-host disease.
@en
P2093
Castro-Malaspina HR
Dastigir H
Jakubowski AA
Lomazow WA
O'Reilly RJ
P2888
P304
P356
10.1038/SJ.BMT.1705762
P407
P577
2007-07-09T00:00:00Z